Tonix Pharmaceuticals Holding Corp.

US$4.74As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TNXPHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (83.27%)
Div yield —
ROE (81.82%)
Biotechnology
Beta (5Y) 1.90
PE TTM —
TSR TTM (74.54%)
Mkt cap US$81.30M
ROIC (52.74%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.43
14.47%
(86.36%)
Hold 1|9|7|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.07
0.07
22.89%
21.72%
18.86%
16.64%
Revenue$M
3.889
3.821
3.765
3.763
7.58%
3.91%
1.00%
(2.01%)
Peers (US$81.30M)
Cap (US$)
PE
84.17M
—
81.72M
—
Capital
TTM
5Y
10Y
Leveragex
0.933
(0.600)
(0.550)
EBIT/Intx
0.853
0.146
0.181
Own earn%
(6.32)
28.84
26.86
Sh yield%
38.72
54.98
51.73
Owners
Insiders/Inst%
0.78
47.87
Short interest%
2.92
SBC / revenue%
4.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
5–16
$1 testx
—
Incr. ROIC%
0